Shenzhen Neptunus Bioengineering Co., Ltd.
|
3.67 Billion CNY
|
97.353%
|
Anhui Fengyuan Pharmaceutical Co., Ltd.
|
573.57 Million CNY
|
83.019%
|
Dong-E-E-Jiao Co.,Ltd.
|
1.01 Billion CNY
|
90.38%
|
Livzon Pharmaceutical Group Inc.
|
2.06 Billion CNY
|
95.273%
|
Hainan Haiyao Co., Ltd.
|
320.86 Million CNY
|
69.644%
|
Tus-Pharmaceutical Group Co., Ltd.
|
130.08 Million CNY
|
25.127%
|
Jilin Aodong Pharmaceutical Group Co., Ltd.
|
872.34 Million CNY
|
88.835%
|
Changchun High-Tech Industries (Group) Inc.
|
4.95 Billion CNY
|
98.035%
|
Apeloa Pharmaceutical Co.,Ltd
|
2.08 Billion CNY
|
95.325%
|
PKU HealthCare Corp.,Ltd.
|
184.17 Million CNY
|
47.116%
|
Chengdu Huasun Technology Group Inc., Ltd.
|
108.33 Million CNY
|
10.09%
|
Dezhan Healthcare Company Limited
|
207.56 Million CNY
|
53.074%
|
Jinling Pharmaceutical Company Limited
|
268.06 Million CNY
|
63.665%
|
Jiuzhitang Co., Ltd.
|
961.92 Million CNY
|
89.874%
|
Huapont Life Sciences Co., Ltd.
|
2.67 Billion CNY
|
96.358%
|
Zhejiang Jingxin Pharmaceutical Co., Ltd.
|
652.68 Million CNY
|
85.077%
|
Shandong Wohua Pharmaceutical Co., Ltd.
|
149.08 Million CNY
|
34.669%
|
Hengkang Medical Group Co., Ltd.
|
218.54 Million CNY
|
55.433%
|
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
|
520.39 Million CNY
|
81.283%
|
Qianjiang Yongan Pharmaceutical Co., Ltd.
|
69.89 Million CNY
|
-39.35%
|
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
|
6.65 Billion CNY
|
98.536%
|
Jinhe Biotechnology CO., LTD.
|
670.55 Million CNY
|
85.475%
|
Teyi Pharmaceutical Group Co.,Ltd
|
271.83 Million CNY
|
64.169%
|
Kunming Longjin Pharmaceutical Co., Ltd.
|
28.64 Million CNY
|
-239.971%
|
Beijing Aosaikang Pharmaceutical Co., Ltd.
|
167.48 Million CNY
|
41.847%
|
Chengdu Kanghong Pharmaceutical Group Co., Ltd
|
403.61 Million CNY
|
75.868%
|
Anhui Huangshan Capsule Co., Ltd.
|
122.87 Million CNY
|
20.733%
|
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
|
77.62 Million CNY
|
-25.473%
|
Zhuhai Rundu Pharmaceutical Co., Ltd.
|
415.45 Million CNY
|
76.556%
|
Huaren Pharmaceutical Co., Ltd.
|
334.62 Million CNY
|
70.893%
|
Tianjin Ringpu Bio-Technology Co.,Ltd.
|
389.93 Million CNY
|
75.021%
|
Shanxi Zhendong Pharmaceutical Co.,Ltd
|
1.19 Billion CNY
|
91.852%
|
Fuan Pharmaceutical (Group) Co., Ltd.
|
707.8 Million CNY
|
86.239%
|
Hybio Pharmaceutical Co., Ltd.
|
152.59 Million CNY
|
36.17%
|
Baotou Dongbao Bio-Tech Co.,Ltd
|
281.53 Million CNY
|
65.403%
|
Hunan Er-Kang Pharmaceutical Co., Ltd
|
691.6 Million CNY
|
85.917%
|
Changjiang Pharmaceutical Group Co., Ltd.
|
51.85 Million CNY
|
-87.82%
|
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
|
780.03 Million CNY
|
87.513%
|
Fujian Cosunter Pharmaceutical Co., Ltd.
|
111.47 Million CNY
|
12.626%
|
Beijing Science Sun Pharmaceutical Co., Ltd.
|
107.06 Million CNY
|
9.025%
|
Zhejiang Xinguang Pharmaceutical Co., Ltd.
|
71.41 Million CNY
|
-36.379%
|
Hainan Poly Pharm. Co., Ltd
|
359.05 Million CNY
|
72.873%
|
Jiangxi Synergy Pharmaceutical Co., Ltd.
|
523.41 Million CNY
|
81.391%
|
Wuhan Hiteck Biological Pharma Co.,Ltd
|
117.41 Million CNY
|
17.046%
|
Shandong Xinhua Pharmaceutical Company Limited
|
1.31 Billion CNY
|
92.582%
|
Zhejiang Tianyu Pharmaceutical Co., Ltd.
|
1.88 Billion CNY
|
94.846%
|
PharmaBlock Sciences (Nanjing), Inc.
|
724.78 Million CNY
|
86.562%
|
Jinghua Pharmaceutical Group Co., Ltd.
|
290.94 Million CNY
|
66.522%
|
Zhejiang Hisoar Pharmaceutical Co., Ltd.
|
702.27 Million CNY
|
86.131%
|
Betta Pharmaceuticals Co., Ltd.
|
327.5 Million CNY
|
70.26%
|
Tibet AIM Pharm. Inc.
|
58.96 Million CNY
|
-65.173%
|
Shenzhen Kangtai Biological Products Co., Ltd.
|
772.85 Million CNY
|
87.397%
|
Shandong Shanda Wit Science and Technology Co., Ltd.
|
86.54 Million CNY
|
-12.541%
|
Pacific Shuanglin Bio-pharmacy Co., LTD
|
909.37 Million CNY
|
89.289%
|
Zhejiang AngLiKang Pharmaceutical CO.,LTD.
|
393.44 Million CNY
|
75.244%
|
Xiamen Kingdomway Group Company
|
715.82 Million CNY
|
86.393%
|
ShanXi C&Y Pharmaceutical Group Co., Ltd.
|
120.83 Million CNY
|
19.391%
|
Walvax Biotechnology Co., Ltd.
|
1.03 Billion CNY
|
90.586%
|
Sunflower Pharmaceutical Group Co.,Ltd
|
873.18 Million CNY
|
88.845%
|
Harbin Gloria Pharmaceuticals Co., Ltd
|
190.66 Million CNY
|
48.916%
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
|
5.11 Billion CNY
|
98.095%
|
Hunan Hansen Pharmaceutical Co., Ltd.
|
231.12 Million CNY
|
57.858%
|
Changzhou Qianhong Biopharma CO.,LTD
|
602.01 Million CNY
|
83.821%
|
Shenzhen Weiguang Biological Products Co., Ltd.
|
672.98 Million CNY
|
85.527%
|
Honz Pharmaceutical Co., Ltd.
|
236.42 Million CNY
|
58.804%
|
Northeast Pharmaceutical Group Co., Ltd.
|
1.36 Billion CNY
|
92.86%
|
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
|
369.16 Million CNY
|
73.616%
|
Guizhou Xinbang Pharmaceutical Co., Ltd.
|
1 Billion CNY
|
90.268%
|
Tianjin Lisheng Pharmaceutical Co.,Ltd.
|
176.28 Million CNY
|
44.748%
|
Zhejiang Yatai Pharmaceutical Co., Ltd.
|
89.47 Million CNY
|
-8.858%
|
Zhejiang NHU Company Ltd.
|
4.31 Billion CNY
|
97.745%
|
ApicHope Pharmaceutical Co., Ltd
|
346.43 Million CNY
|
71.885%
|
Shanghai Kaibao Pharmaceutical CO.,Ltd
|
171.79 Million CNY
|
43.304%
|
Beijing SL Pharmaceutical Co., Ltd.
|
144.45 Million CNY
|
32.575%
|
Yunnan Baiyao Group Co.,Ltd
|
6.44 Billion CNY
|
98.488%
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
|
94.1 Million CNY
|
-3.503%
|
Guangdong Lifestrong Pharmacy Co., Ltd.
|
83.43 Million CNY
|
-16.739%
|
Huadong Medicine Co., Ltd
|
4.29 Billion CNY
|
97.73%
|
Jiangsu Nhwa Pharmaceutical Co., LTD
|
628.63 Million CNY
|
84.506%
|
Harbin Medisan Pharmaceutical Co., Ltd.
|
208.78 Million CNY
|
53.349%
|
LanZhou Foci Pharmaceutical Co.,Ltd.
|
369.72 Million CNY
|
73.656%
|
Tianjin Chase Sun Pharmaceutical Co.,Ltd
|
1.96 Billion CNY
|
95.033%
|
Beijing Beilu Pharmaceutical Co., Ltd
|
244.85 Million CNY
|
60.222%
|
Nanjing Hicin Pharmaceutical Co., Ltd.
|
81.45 Million CNY
|
-19.575%
|
Renhe Pharmacy Co., Ltd.
|
446.57 Million CNY
|
78.19%
|
Chongqing Pharscin Pharmaceutical Co., Ltd.
|
151.67 Million CNY
|
35.784%
|
Zhejiang Xianju Pharmaceutical Co.,Ltd.
|
922.87 Million CNY
|
89.446%
|
Luoxin Pharmaceuticals Group Stock Co., Ltd.
|
455.61 Million CNY
|
78.622%
|
Guizhou Bailing Group Pharmaceutical Co., Ltd.
|
1.16 Billion CNY
|
91.63%
|